Benefits and Challenges of Successfully Implementing the Direct to Patient Model – 3

25 October 2018
Available Seats:

The attendee will be able to:

1. Describe two (2) benefits each for the clinical site, sponsor and patient of a direct to patient trial
2. Identify at least two (2) risks for sponsors and develop an effective mitigation strategy for these risks
3. Identify two (2) late stage customization strategies that can support delivery of medication closer to the patient thus minimizing waste

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.